Proposals for Chemical Investments

Understand the details before investing

HDPE Pellets - Exports

Project Overview:

Investment opportunity in the export of HDPE (High-Density Polyethylene) pellets to the Indian market.
Strong demand and established buyer network ensure consistent cash flow.
Strategic supply chain in place for seamless logistics and operations.

🔹 Key Highlights:

Target Export Volume: 2,000 Metric Tons over the first 6 months.
Minimum Investment Amount: AED 200,000.
Annual Returns: 14% per annum, paid annually.
Investment Tenure: Minimum commitment of 2 years.
Security: Structured trade-backed investment with goods as collateral during transit and processing.
Market Potential: India’s demand for HDPE pellets continues to rise with rapid industrial and packaging sector growth.
Regulatory Compliance: All exports fully compliant with UAE and Indian trade regulations.

🔹 Why Invest:

Stable and inflation-hedged returns.
Access to a high-growth commodity export market.
Transparent financial reporting and investor communication.
Operated by an experienced team with a strong track record in commodity trade and capital management.

Know More

Carbon Capture Utilization - Research

Offered by: Gains and Wells Capital
Total Project Cost: AED 6,000,000
Minimum Investment Size: AED 300,000
Investment Tenure: 3 Years
Estimated ROI: 20% per annum (Through IPR)

🔹 Project Overview

This project aims to capture carbon dioxide (CO₂) emissions from industrial sources and convert them into commercially valuable products such as construction materials, synthetic fuels, and specialty chemicals.
The technology is aligned with global climate goals and supports UAE’s Net Zero 2050 initiative.

🔹 Key Features

Sector: CleanTech / Environmental Engineering
Technology: Modular, scalable carbon capture units with integrated CO₂ conversion systems.
Location: UAE (with potential partnerships in industrial zones and manufacturing clusters)
Output: Usable CO₂-based products with commercial applications.
Sustainability Impact: Expected reduction of 10,000+ tons of CO₂ emissions per year in Phase 1.

🔹 Investment Highlights

Minimum Investment: AED 300,000
Total Capital Required: AED 6,000,000
Investment Period: 3 years
Projected Returns: 14% annualized return, with option for reinvestment in expansion phases.
IP Opportunity: Investors will hold co-rights in the developed IP and technology platform.
Exit Strategy: Revenue generation through product sales, licensing of the tech, or technology transfer deals with government or private sector partners.

🔹 Why Invest

Backed by experienced researchers and a scalable prototype ready for field deployment.
Strong commercial interest in carbon-based construction materials and fuels.
Opportunity to own a stake in a proprietary green technology with long-term licensing potential.
Contribution to climate-positive action with measurable ESG impact.

Know More

Neurotechnology & Brain-Computer Interface (BCI) Innovation

This groundbreaking project focuses on the development of next-generation Brain-Computer Interfaces (BCIs) — devices that enable direct communication between the human brain and external systems.

The technology has vast application across:

Medical therapeutics (e.g., treatment of paralysis, epilepsy, and neurodegenerative disorders)
Assistive technology (e.g., communication tools for individuals with disabilities)
Cognitive enhancement and AI-human collaboration
Gaming and immersive AR/VR experiences

The project aims to create patentable BCI systems integrating:

Non-invasive neural sensors
AI-based signal decoding algorithms
Custom hardware for real-time interaction

🔹 Investment Highlights

Total Project Cost: AED 10 million
Minimum Investment Size: AED 500,000
Tenure: 3 years
Projected ROI: 25% per annum, earned via monetization of IPR (licensing, tech transfer, and product commercialization)
Ownership Rights: Investors will be co-holders of the intellectual property developed during the project lifecycle

🔹 Key Differentiators

IP-Driven Returns: Returns generated through global IP licensing, co-development deals, and strategic tech collaborations.
Global Market Access: High demand in US, EU, and Asia for BCI tech in healthcare, defense, and consumer electronics.
Expert R&D Team: Collaboration with top-tier neuroscientists, AI engineers, and medical research institutions in Europe and the Middle East.
First-Mover Advantage: Early entry into a frontier technology expected to shape the next era of human-computer interaction.

🔹 Why Invest

Own a share in cutting-edge neurotechnology IP with global commercial potential.
Participate in a high-growth, high-impact sector at the intersection of biotech, AI, and neuroscience.
Enjoy exceptional annual returns with long-term value through IP royalties, licensing, and acquisition opportunities.
Contribute to transforming lives through assistive and therapeutic technology.

Know More